ArticleFrontiers in oncology2025
Prevalence and risk factors of frailty in patients with gynecological malignancies after surgery and chemotherapy: a cross-sectional study.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Frailty is a significant factor influencing the prognosis of patients with gynecological malignancies. Surgery and chemotherapy are key components of cancer treatment; however, limited research has addressed frailty and its associated risk factors in this patient population. This study aimed to determine the prevalence of frailty and identify its associated factors in patients with gynecological malignancies following surgery and chemotherapy. Method: This cross-sectional study was conducted at two tertiary hospitals in Shanghai between January and September 2024. Patients completed five assessment scales, including the Demographic Information Scale, Vulnerable Elders Survey-13 (VES-13), Athens Insomnia Scale (AIS), Depression Anxiety Stress Scale-21 (DASS-21), and Perceived Social Support Scale (PSSS), to screen for frailty and related factors. Multivariate logistic regression analysis was used to identify risk factors for frailty, with 95% confidence intervals (CIs) used to estimate the strength of the associations. Result: A total of 211 eligible inpatients with gynecological malignancies who had undergone surgery and chemotherapy were recruited. The prevalence of frailty in these patients was 64.9%. Multivariate logistic regression analysis identified several risk factors for frailty: older age, underweight status, stress, insomnia, married status, high white blood cell count, and low albumin levels. Conclusion: This study highlights the relatively high prevalence of frailty among patients with gynecological malignancies after surgery and chemotherapy. Understanding the factors associated with frailty is crucial for implementing timely interventions that can improve health-related quality of life and treatment outcomes in this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.